Monthly information on share capital and company voting rights
Rhea-AI Summary
Cellectis has released its monthly update on share capital and voting rights as of May 31, 2024. The company, listed on Euronext Growth with ISIN code FR0010425595, reports a total of 100,093,635 shares in its capital. The number of voting rights stands at 88,029,374. For more details, media and investor relations contacts are provided.
Positive
- The company has a substantial number of shares, indicating a large capital base.
- Maintaining regular updates on share capital and voting rights promotes transparency.
Negative
- The voting rights are significantly lower than the total number of shares, potentially indicating diluted voting power for shareholders.
News Market Reaction 1 Alert
On the day this news was published, CLLS declined 2.20%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, June 05, 2024 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 05/31/2024 | 100,093,635 | 88,029,374 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com
Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577
Attachment
FAQ
What is the total number of shares for Cellectis as of May 31, 2024?
How many voting rights does Cellectis have as of May 31, 2024?
On which market is Cellectis listed?
What is the ISIN code for Cellectis?
Who can I contact for more information about Cellectis?
